Molecular Pathways: Can Activin-Like Kinase Pathway Inhibition Enhance the Limited Efficacy of VEGF Inhibitors?

por Bhatt, Rupal S., Atkins, Michael B.
Publicado 2014

Rapid Development of Hypertension by Sorafenib: Toxicity or Target?

por Humphreys, Benjamin D., Atkins, Michael B.
Publicado 2009

Future Directions in Renal Cell Carcinoma: 2011 and Beyond

por Cho, Daniel C., Atkins, Michael B.
Publicado 2011

PD-1 as a potential target in cancer therapy

por McDermott, David F, Atkins, Michael B
Publicado 2013

Advances in immunotherapy for melanoma

por Redman, Jason M., Gibney, Geoffrey T., Atkins, Michael B.
Publicado en BMC Med (2016)

Predictive biomarkers for checkpoint inhibitor-based immunotherapy

por Gibney, Geoffrey T, Weiner, Louis M, Atkins, Michael B
Publicado en Lancet Oncol (2016)

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy

por Serzan, Michael T, Kumar, Princy N, Atkins, Michael B
Publicado en J Immunother Cancer (2020)

Management of metastatic renal cell carcinoma in patients with poor prognosis

por Bullock, Andrea, McDermott, David F, Atkins, Michael B
Publicado 2010

What’s new in melanoma? Combination!

por Ascierto, Paolo A, Marincola, Francesco M, Atkins, Michael B
Publicado en J Transl Med (2015)

Second‐Line Treatment Landscape for Renal Cell Carcinoma: A Comprehensive Review

por Tannir, Nizar M., Pal, Sumanta K., Atkins, Michael B.
Publicado en Oncologist (2018)

Indoor Tanning Dependence in Young Adult Women

por Mays, Darren, Atkins, Michael B., Ahn, Jaeil, Tercyak, Kenneth P.
Publicado en Cancer Epidemiol Biomarkers Prev (2017)

A case of checkpoint inhibitor-induced celiac disease

por Alsaadi, Dana, Shah, Neil J., Charabaty, Aline, Atkins, Michael B.
Publicado en J Immunother Cancer (2019)

Toxicities of Immunotherapy for the Practitioner

por Weber, Jeffrey S., Yang, James C., Atkins, Michael B., Disis, Mary L.
Publicado en J Clin Oncol (2015)

Treatment Selection for Patients With Metastatic Renal Cell Carcinoma

por Atkins, Michael B., Choueiri, Toni K., Cho, Daniel, Regan, Meredith, Signoretti, Sabina
Publicado 2009

Emerging Role of Vedolizumab in Managing Refractory Immune Checkpoint Inhibitor–Induced Enteritis

por Diana, Pietro, Mankongpaisarnrung, Charoen, Atkins, Michael B., Zeck, Jay C., Charabaty, Aline
Publicado en ACG Case Rep J (2018)

Ipilimumab associated colitis: An IpiColitis case series at MedStar Georgetown University Hospital

por Rastogi, Pawan, Sultan, Mohamed, Charabaty, Aline J, Atkins, Michael B, Mattar, Mark C
Publicado en World J Gastroenterol (2015)

Support for indoor tanning policies among young adult women who indoor tan

por Mays, Darren, Murphy, Sarah E., Bubly, Rachel, Atkins, Michael B., Tercyak, Kenneth P.
Publicado en Transl Behav Med (2016)

Evolving impact of long-term survival results on metastatic melanoma treatment

por Michielin, Olivier, Atkins, Michael B, Koon, Henry B, Dummer, Reinhard, Ascierto, Paolo Antonio
Publicado en J Immunother Cancer (2020)

Correlates of sun safety practices in a racial/ethnically diverse sample of adolescents: Implications for skin cancer prevention interventions

por Mays, Darren, Hawkins, Kirsten B., Tyc, Vida L., Atkins, Michael B., Tercyak, Kenneth P.
Publicado en Pediatr Dermatol (2015)

Genetic Associations with Indoor Tanning Addiction among non-Hispanic White Young Adult Women

por Mays, Darren, Ahn, Jaeil, Zhang, Bingsong, Atkins, Michael B, Goerlitz, David, Tercyak, Kenneth P
Publicado en Ann Behav Med (2019)